SAN DIEGO--(BUSINESS WIRE)--Jan. 4, 2006--Illumina, Inc. (NASDAQ:ILMN) announced today that Jay Flatley, President and CEO, will present an overview of the Company's commercial and product development activity at the upcoming JP Morgan Healthcare Conference in San Francisco, CA.

Mr. Flatley's presentation will be webcast live beginning on or about 8:00 a.m. Pacific Time (PT) on Thursday, January 12, 2006. The webcast presentation may be accessed at http://equityconferences.jpmorgan.com/where it will be archived for 30 days following the presentation.

Illumina (www.illumina.com) is developing next-generation tools that permit large-scale analysis of genetic variation and function. The Company's proprietary BeadArray(TM) technology -- now used in leading genome centers around the world -- provides the throughput, cost effectiveness and flexibility to enable researchers in the life sciences and pharmaceutical industries to perform the billions of tests necessary to extract medically valuable information from advances in genomics and proteomics. This information will help pave the way to personalized medicine by correlating genetic variation and gene function with particular disease states, enhancing drug discovery, allowing diseases to be detected earlier and more specifically, and permitting better choices of drugs for individual patients.

CONTACT: Illumina, Inc.
Jay Flatley, 858-202-4501
jflatley@illumina.com
or
William Craumer, 858-202-4667
bcraumer@illumina.com
SOURCE: Illumina, Inc.